JW중외제약

001060KOSPI의약품 제조업

57.5 / 100

Reference Date: 2026-06-10

Financial Score23.5 / 40

News Sentiment18.0 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but Operating Profit is on a declining trend. Declined 14.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

JW Chungwa Pharmaceutical focuses on the research, development, manufacturing, and sales of pharmaceuticals, leveraging a strong pipeline of original drugs such as Rivaro and Winnerf, along with a global R&D network. The company offers a diverse range of specialty and over-the-counter medications, as well as healthcare products, maintaining a competitive edge in both domestic and international markets.

Number of Employees

1,106people

Average Salary

64.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

10.30Industry Average 11.935.0Point

In line with industry avg

PBR

1.65Industry Average 0.891.0Point

1.9x industry avg (risky)

ROE

17.60Industry Average 4.017.0Point

4.4x industry avg (excellent)

Debt Ratio

7.24Industry Average 12.435.0Point

Lower than industry avg (good)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.9% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼1.6% (2-year basis)

ROE Trend

4.0 / 4

Avg ROE 18.4% (improving, 3yr)

Detailed News Sentiment

28 totalPositive 18Neutral 8Negative 2Average Sentiment Score 72

Positive
[신제품·신기술]JW중외제약, 저용량 이상지질증약 ‘리바로젯 1/10㎎...
JW중외제약의 새로운 저용량 이상지질증 치료제 출시로 인해 시장 경쟁력 강화 및 환자 선택 폭 확대 기대.
Neutral
'제2의 판교' 과천 뜬다...게임·IT·바이오 등 기업 잇따라 둥지
과천 지식정보타운의 성장이 관련 산업에 긍정적 영향을 미칠 것으로 보이나, JW중외제약의 직접적인 영향은 제한적입니다.
Neutral
기업 800여 곳 입주한 과천 지식정보타운…판교형 성장 모델과 유사
과천 지식정보타운의 성장이 관련 산업 분야에 긍정적 영향을 미칠 수 있으나, JW중외제약의 직접적인 영향은 제한적이다.

Detailed Momentum

52-week position3.0Point

52w lower range (28%)

Current 26,100Won52-week high 39,05052-week low 20,950

1-month return1.0Point

1m -14.43% (falling)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0

Neutral기업지배구조보고서공시2026-06-01
Neutral분기보고서 (2026.03)2026-05-15
Neutral영업(잠정)실적(공정공시)2026-05-12